ADRs of CSL Limited (OTCQX:CSLLY) dropped ~16% on Tuesday as Wall Street reacted to Australian biotech’s plans to lay off 15% of its workforce, announced in conjunction with its fiscal 2025 financials ...
Shares of CSL Limited Sponsored ADR (CSLLY) have been struggling lately and have lost 14.2% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean ...
Brokers see significantly more upside ahead for Pro Medicus. The post Forget CSL shares, this ASX healthcare stock could double in value appeared first on The Motley Fool Australia.
An announcement from CSL ( (AU:CSL)) is now available. CSL Limited has provided an updated notification to the ASX on the progress of its on-market share buy-back program for ordinary fully paid ...
Fintel reports that on December 8, 2025, JEFFERIES maintained coverage of CSL Limited - Depositary Receipt (OTCPK:CSLLY) with a Buy recommendation. As of December 6, 2025, the average one-year price ...
Zacks.com on MSN
CSLLY vs. ARGX: Which Stock Is the Better Value Option?
Investors looking for stocks in the Medical - Biomedical and Genetics sector might want to consider either CSL Limited Sponsored ADR (CSLLY) or argenex SE (ARGX). But which of these two stocks is more ...
The last available hemophilia gene therapy is temporarily unavailable, according to CSL Behring. | The company is working ...
CSL ( (AU:CSL)) has issued an announcement. CSL Limited has provided an updated notification to the ASX regarding its ongoing on-market share buy-back program for its ordinary fully paid shares. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results